Tapewire

Nasdaq · USD

MODD

Modular Medical, Inc.

Export transactions ↓
Tapewire entity
7488
SEC CIK
0001074871
Parsed reports
252

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2024 Filed Oct 2, 2024 10:14 UTC GrantCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-084294 · ownership.xml · nonDerivative · entry 1

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,677

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
August 22, 2024 Filed Aug 26, 2024 21:56 UTC
DiPerna PaulDirector · See Remarks · 10% owner
GrantOption to purchase common stock · Derivative 58,560 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001213900-24-072662 · ownership.xml · derivative · entry 1

DiPerna Paul · CIK 0001506126 · Director · See Remarks · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,560

Underlying: Common Stock · 58,560 shares

Expires 2034-08-22

F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) pre-market submission for the Registrant's initial pump product on or before December 31, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on January 1, 2025.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
August 22, 2024 Filed Aug 26, 2024 21:55 UTC
Schmid KevinChief Operating Officer
GrantOption to purchase common stock · Derivative 24,400 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001213900-24-072660 · ownership.xml · derivative · entry 1

Schmid Kevin · CIK 0001395775 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,400

Underlying: Common Stock · 24,400 shares

Expires 2034-08-22

F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) pre-market submission for the Registrant's initial pump product on or before December 31, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on January 1, 2025.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
August 19, 2024 Filed Aug 21, 2024 10:01 UTC PurchaseCommon Stock 15,000 $1.69 $25,350.00
Disclosure

SEC source: 0001213900-24-071254 · ownership.xml · nonDerivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,139

Read SEC document
June 30, 2024 Filed Jul 2, 2024 22:55 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001213900-24-058725 · ownership.xml · derivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:57 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001213900-24-058707 · ownership.xml · derivative · entry 2

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:56 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001213900-24-058705 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:54 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001213900-24-058703 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:30 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0000919574-24-003862 · ownership.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:30 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 1,875 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0000919574-24-003862 · ownership.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2034-06-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 28, 2024 Filed Jul 3, 2024 01:59 UTC GrantCommon stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058775 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,890

F1 · security: Includes restricted stock units ("RSUs") granted to the Reporting Person on July 5, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The RSUs vest on a quarterly basis over a three-year period, subject to the Reporting Person's continuous service with the Issuer.

F2 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 21:57 UTC GrantCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058707 · ownership.xml · nonDerivative · entry 1

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,927

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 21:54 UTC GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058703 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,210

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 23:41 UTC
DiPerna PaulDirector · See Remarks · 10% owner
GrantOption to purchase common stock · Derivative 100,000 $1.52 Strike: $1.52 $152,000.00
Disclosure

SEC source: 0001213900-24-031687 · ownership.xml · derivative · entry 1

DiPerna Paul · CIK 0001506126 · Director · See Remarks · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-04-08

F1 · security: This option shall vest as to 1/3rd of the shares subject to the option on April 8, 2025 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
April 08, 2024 Filed Apr 9, 2024 23:28 UTC
Schmid KevinChief Operating Officer
GrantOption to purchase common stock · Derivative 50,000 $1.52 Strike: $1.52 $76,000.00
Disclosure

SEC source: 0001213900-24-031683 · ownership.xml · derivative · entry 1

Schmid Kevin · CIK 0001395775 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-04-08

F1 · security: This option shall vest as to 1/3rd of the shares subject to the option on April 8, 2025 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2024 Filed Apr 3, 2024 01:52 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0001213900-24-029554 · ownership.xml · derivative · entry 2

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2024 Filed Apr 3, 2024 01:36 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0001213900-24-029547 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2024 Filed Apr 3, 2024 01:34 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0001213900-24-029545 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2024 Filed Apr 4, 2024 14:28 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0000919574-24-002337 · ownership.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2024 Filed Apr 4, 2024 14:28 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 1,875 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0000919574-24-002337 · ownership.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2034-03-31

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 29, 2024 Filed Apr 3, 2024 01:36 UTC GrantCommon Stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-029548 · ownership.xml · nonDerivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,139

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
March 29, 2024 Filed Apr 3, 2024 01:52 UTC GrantCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-029554 · ownership.xml · nonDerivative · entry 1

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,177

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
March 29, 2024 Filed Apr 3, 2024 01:35 UTC GrantCommon stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-029546 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,981

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
March 29, 2024 Filed Apr 3, 2024 01:34 UTC GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-029545 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,585

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
March 29, 2024 Filed Jul 3, 2024 01:59 UTC Amendment GrantCommon stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058774 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,390

F1 · security: Includes restricted stock units ("RSUs") granted to the Reporting Person on July 5, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The RSUs vest on a quarterly basis over a three-year period, subject to the Reporting Person's continuous service with the Issuer.

F2 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 16:50 UTC
MANCHESTER MANAGEMENT CO LLCDirector · 10% owner · Director by Deputization
MANCHESTER MANAGEMENT PR, LLCDirector · 10% owner · Director by Deputization
BESSER JAMES EChief Executive Officer · 10% owner
Manchester Explorer, L.P.Director by Deputization
JEB Partners, L.P.Director by Deputization
PurchaseCommon Stock, par value $0.001 per share 900,000 $1.10 $990,000.00
Disclosure

SEC source: 0000919574-24-001612 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · Director · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · Director · 10% owner · Director by Deputization

BESSER JAMES E · CIK 0001512127 · Chief Executive Officer · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · Director by Deputization

JEB Partners, L.P. · CIK 0001093241 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 3,118,227

F1 · ownership.direct: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
February 16, 2024 Filed Nov 26, 2024 00:25 UTC Amendment
MANCHESTER MANAGEMENT CO LLCDirector · 10% owner · Director by Deputization
MANCHESTER MANAGEMENT PR, LLCDirector · 10% owner · Director by Deputization
BESSER JAMES EChief Executive Officer · 10% owner
Manchester Explorer, L.P.Director by Deputization
PurchaseCommon Stock, par value $0.001 per share 900,000 $1.10 $990,000.00
Disclosure

SEC source: 0000919574-24-006889 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · Director · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · Director · 10% owner · Director by Deputization

BESSER JAMES E · CIK 0001512127 · Chief Executive Officer · 10% owner

Manchester Explorer, L.P. · CIK 0001411524 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 3,118,077

F1 · security: The original Form 4 is being amended to update the beneficial ownership information reported therein.

F2 · ownership.direct: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) and James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 02:05 UTC GrantCommon Stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-000404 · ownership.xml · nonDerivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,639

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:18 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0001213900-24-000372 · ownership.xml · derivative · entry 2

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:18 UTC GrantCommon Stock 750 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-000372 · ownership.xml · nonDerivative · entry 1

FELSHER STEVEN G · CIK 0001231460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,427

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:15 UTC GrantCommon stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-000368 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,558

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:13 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0001213900-24-000366 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:11 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0001213900-24-000364 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:11 UTC GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-000364 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,960

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 22:54 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0000919574-24-000044 · ownership.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jan 3, 2024 22:54 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 1,875 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0000919574-24-000044 · ownership.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2033-12-29

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jul 3, 2024 01:57 UTC Amendment GrantCommon stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058772 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,890

F1 · security: Includes restricted stock units ("RSUs") granted to the Reporting Person on July 5, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock once vested. The RSUs vest on a quarterly basis over a three-year period, subject to the Reporting Person's continuous service with the Issuer.

F2 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
November 01, 2023 Filed Nov 1, 2023 20:01 UTC PurchaseCommon Stock 10,000 $1.29 $12,900.00
Disclosure

SEC source: 0001213900-23-082156 · ownership.xml · nonDerivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,139

Read SEC document
October 16, 2023 Filed Oct 18, 2023 10:29 UTC
MANCHESTER MANAGEMENT CO LLC10% owner · Director by Deputization
MANCHESTER MANAGEMENT PR, LLC10% owner · Director by Deputization
BESSER JAMES EChief Executive Officer · 10% owner
JEB Partners, L.P.Director by Deputization
PurchaseCommon Stock, par value $0.001 per share 20,000 $1.10 $21,974.00
Disclosure

SEC source: 0000919574-23-005719 · ownership.xml · nonDerivative · entry 2

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

BESSER JAMES E · CIK 0001512127 · Chief Executive Officer · 10% owner

JEB Partners, L.P. · CIK 0001093241 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,750

F2 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity.

Read SEC document
October 16, 2023 Filed Oct 18, 2023 10:29 UTC
MANCHESTER MANAGEMENT CO LLC10% owner · Director by Deputization
MANCHESTER MANAGEMENT PR, LLC10% owner · Director by Deputization
BESSER JAMES EChief Executive Officer · 10% owner
JEB Partners, L.P.Director by Deputization
PurchaseCommon Stock, par value $0.001 per share 13,000 $1.04 $13,548.60
Disclosure

SEC source: 0000919574-23-005719 · ownership.xml · nonDerivative · entry 1

MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization

MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization

BESSER JAMES E · CIK 0001512127 · Chief Executive Officer · 10% owner

JEB Partners, L.P. · CIK 0001093241 · Director by Deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote.

Disclosed balance after: 330,473

F1 · ownership.nature: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company LLC ("Manchester Management"), the general partner of JEB Partners, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 22:00 UTC
BESSER JAMES EChief Executive Officer · 10% owner
GrantOption to purchase common stock · Derivative 135,136 $1.11 Strike: $1.11 $150,000.96
Disclosure

SEC source: 0000919574-23-005469 · ownership.xml · derivative · entry 1

BESSER JAMES E · CIK 0001512127 · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,136

Underlying: Common Stock · 135,136 shares

Expires 2033-10-02

F1 · security: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product must be completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product must be completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:05 UTC
Schmid KevinChief Operating Officer
GrantOption to purchase common stock · Derivative 18,769 $1.11 Strike: $1.11 $20,833.59
Disclosure

SEC source: 0001013762-23-001575 · ownership.xml · derivative · entry 2

Schmid Kevin · CIK 0001395775 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,769

Underlying: Common Stock · 18,769 shares

Expires 2033-10-02

F1 · security: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F3 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:05 UTC
Schmid KevinChief Operating Officer
GrantOption to purchase common stock · Derivative 37,538 $1.11 Strike: $1.11 $41,667.18
Disclosure

SEC source: 0001013762-23-001575 · ownership.xml · derivative · entry 1

Schmid Kevin · CIK 0001395775 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,538

Underlying: Common Stock · 37,538 shares

Expires 2033-10-02

F1 · security: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:05 UTC
DiPerna PaulDirector · See Remarks · 10% owner
GrantOption to purchase common stock · Derivative 45,046 $1.11 Strike: $1.11 $50,001.06
Disclosure

SEC source: 0001013762-23-001574 · ownership.xml · derivative · entry 2

DiPerna Paul · CIK 0001506126 · Director · See Remarks · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,046

Underlying: Common Stock · 45,046 shares

Expires 2033-10-02

F3 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:05 UTC
DiPerna PaulDirector · See Remarks · 10% owner
GrantOption to purchase common stock · Derivative 90,091 $1.11 Strike: $1.11 $100,001.01
Disclosure

SEC source: 0001013762-23-001574 · ownership.xml · derivative · entry 1

DiPerna Paul · CIK 0001506126 · Director · See Remarks · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,091

Underlying: Common Stock · 90,091 shares

Expires 2033-10-02

F1 · derivative.exercise_date: This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2023 Filed Oct 2, 2023 21:50 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.16 Not disclosed
Disclosure

SEC source: 0000919574-23-005448 · ownership.xml · derivative · entry 2

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Common Stock · 7,500 shares

Expires 2033-09-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2023 Filed Oct 2, 2023 21:50 UTC
FRANK MORGAN C.Director · 10% owner
GrantOption to purchase common stock · Derivative 1,875 Not disclosed Strike: $1.16 Not disclosed
Disclosure

SEC source: 0000919574-23-005448 · ownership.xml · derivative · entry 1

FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2033-09-30

F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F1 · price: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2023 Filed Oct 3, 2023 10:13 UTC GrantCommon stock 2,390 Not disclosed Not disclosed
Disclosure

SEC source: 0001013762-23-000722 · ownership.xml · nonDerivative · entry 1

DeSisto Duane M · CIK 0001365746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,724

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 10:09 UTC GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.16 Not disclosed
Disclosure

SEC source: 0001013762-23-000714 · ownership.xml · derivative · entry 1

Vos Ellen O'Connor · CIK 0001534357 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-09-30

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F1 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2023 Filed Oct 3, 2023 10:07 UTC GrantCommon Stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001013762-23-000711 · ownership.xml · nonDerivative · entry 1

Sheibley Philip Brent · CIK 0001895043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,139

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.